Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation

Published:2017-11 Issue:11 Volume:48 Page:3040-3048
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Cha Myung-Jin¹,Choi Eue-Keun¹,Han Kyung-Do¹,Lee So-Ryoung¹,Lim Woo-Hyun¹,Oh Seil¹,Lip Gregory Y.H.¹

Affiliation:

1. From the Department of Internal Medicine, Seoul National University Hospital, Republic of Korea (M.-J.C., E.-K.C., S.O.); Department of Biostatistics, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea (K.-D.H.); Department of Internal Medicine, Soonchunhyang University Hospital Seoul, Republic of Korea (S.-R.L.); Division of Cardiology, Department of Internal Medicine, Seoul National University Boramae Medical Center, Republic of Korea (W.-H.L.); Institute of Cardiovascular...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference30 articles.

1. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

2. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

3. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

4. Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice

5. Dabigatran in real-world atrial fibrillation

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between physical activity changes and incident myocardial infarction after ischemic stroke: a nationwide population-based study;BMC Public Health;2024-05-06

2. A Common Data Model for Oral Anticoagulants-related Risk of Spontaneous Intracranial Hemorrhage (Preprint);2024-05-01

3. Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation;Scientific Reports;2024-04-29

4. The Prescription trends and dosing appropriateness analysis of novel oral anticoagulants in ischemic stroke patients: a retrospective study of 9 cities in China;Frontiers in Pharmacology;2024-03-12

5. Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation Patients From Asia　― One-Year Data From the Global ETNA-AF Program ―;Circulation Reports;2024-03-08